ZHI TAN to Drug Discovery
This is a "connection" page, showing publications ZHI TAN has written about Drug Discovery.
Connection Strength
1.212
-
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor. Sci Rep. 2016 09 21; 6:33534.
Score: 0.481
-
Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2122506119.
Score: 0.178
-
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
Score: 0.170
-
An up-to-date overview of computational polypharmacology in modern drug discovery. Expert Opin Drug Discov. 2020 09; 15(9):1025-1044.
Score: 0.155
-
Computational polypharmacology: a new paradigm for drug discovery. Expert Opin Drug Discov. 2017 Mar; 12(3):279-291.
Score: 0.123
-
Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2413108121.
Score: 0.053
-
On-demand modular assembly for expedited PROTAC development. Expert Opin Drug Discov. 2024 Jul; 19(7):769-772.
Score: 0.051